MANIPALHOS NSE filing

Manipal Health Q2 FY27 Revenue surges 37% to ₹3,400 Crore; EBITDA up 30%

The RealCase readHigh impact Positive

Manipal Health Enterprises reported its best-ever quarter in Q2 FY27, with revenue surging 37% to ₹3,400 crore and EBITDA up 30% to ₹882 crore. Patient volumes increased significantly, driving occupancy to 70%. The company also announced plans to add 440-500 beds in H2 FY27 and completed the acquisition of Kinder Hospital.

Why it matters

The announcement details strong financial performance, including record revenue and EBITDA growth, alongside strategic expansion plans and acquisitions. These factors are highly material for investors and indicate significant company progress.

The market read

The company reported record-breaking financial results with significant year-on-year growth in revenue and EBITDA, driven by strong volume growth and improved occupancy rates. Expansion plans and strategic acquisitions further contribute to a positive outlook.

Manipal Health Enterprises Limited announced its financial results for the quarter and half-year ended September 30, 2026. The company reported its best-ever quarter, with Q2 FY27 revenue reaching ₹3,400 crore, a significant 37% increase compared to Q2 FY26. EBITDA for the quarter stood at ₹882 crore, up 30% year-on-year.

The growth was primarily driven by increased patient volumes, with inpatient volumes rising by 35% and outpatient volumes by 27%. Average occupancy across the network increased to 70% in Q2 FY27 from 65% in Q1 FY27. Average revenue per occupied bed per day (ARPOB) saw an 8% growth year-on-year, reaching ₹77,000 excluding Sahyadri.

For the first half of FY27, revenue grew by 38% to ₹6,490 crore, with network EBITDA at ₹1,631 crore, up 28%. PAT for H1 FY27 was ₹639 crore, representing a 10% margin. Digital revenue contributed 23% to the overall revenue in the first half.

Sahyadri Hospitals also showed strong performance, with Q2 FY27 revenue at ₹375 crore and EBITDA at ₹73 crore, reflecting sequential growth. EBITDA margin improved to 19.5% from 17.5% in Q1 FY27.

The company is expanding its footprint, with plans to add approximately 440-500 beds in H2 FY27 through greenfield and brownfield projects. The acquisition of Kinder Hospital in Bangalore has been completed, and a long-term lease for land in Gurugram for a multi-specialty hospital has also been registered.

Filing to action

What to do with a filing like this

Manipal Health Enterprises Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Manipal Health Enterprises Limited. Read the original for the full detail.

View original filing